Abstract
In recent decades, there has been considerable amount of information about embryonic stem cells (ES). The dilemma facing scientists interested in the development and use of human stem cells in replacement therapies is the source of these cells, i.e. the human embryo. There are many ethical and moral problems related to the use of these cells. Hematopoietic stem cells from umbilical cord blood have been proposed as an alternative source of embryonic stem cells. After exposure to different agents, these cells are able to express antigens of diverse cellular lineages, including the neural type. The In vitro manipulation of human umbilical cord blood (hUCB) cells has shown their stem capacity and plasticity. These cells are easily accessible, In vitro amplifiable, well tolerated by the host, and with more primitive molecular characteristics that give them great flexibility. Overall, these properties open a promising future for the use of hUCB in regenerative therapies for the Central Nervous System (CNS). This review will focus on the available literature concerning umbilical cord blood cells as a therapeutic tool for the treatment of neurodegenerative diseases.
Keywords: Stem cells, umbilical cord blood, neuroregeneration, CNS transplantation, brain injury, neurodegenerative disorders
Current Stem Cell Research & Therapy
Title: Applications of Human Umbilical Cord Blood Cells in Central Nervous System Regeneration
Volume: 5 Issue: 1
Author(s): Antonio S. Herranz, Rafael Gonzalo-Gobernado, Diana Reimers, Maria J. Asensio, Macarena Rodriguez-Serrano and Eulalia Bazan
Affiliation:
Keywords: Stem cells, umbilical cord blood, neuroregeneration, CNS transplantation, brain injury, neurodegenerative disorders
Abstract: In recent decades, there has been considerable amount of information about embryonic stem cells (ES). The dilemma facing scientists interested in the development and use of human stem cells in replacement therapies is the source of these cells, i.e. the human embryo. There are many ethical and moral problems related to the use of these cells. Hematopoietic stem cells from umbilical cord blood have been proposed as an alternative source of embryonic stem cells. After exposure to different agents, these cells are able to express antigens of diverse cellular lineages, including the neural type. The In vitro manipulation of human umbilical cord blood (hUCB) cells has shown their stem capacity and plasticity. These cells are easily accessible, In vitro amplifiable, well tolerated by the host, and with more primitive molecular characteristics that give them great flexibility. Overall, these properties open a promising future for the use of hUCB in regenerative therapies for the Central Nervous System (CNS). This review will focus on the available literature concerning umbilical cord blood cells as a therapeutic tool for the treatment of neurodegenerative diseases.
Export Options
About this article
Cite this article as:
Herranz S. Antonio, Gonzalo-Gobernado Rafael, Reimers Diana, Asensio J. Maria, Rodriguez-Serrano Macarena and Bazan Eulalia, Applications of Human Umbilical Cord Blood Cells in Central Nervous System Regeneration, Current Stem Cell Research & Therapy 2010; 5 (1) . https://dx.doi.org/10.2174/157488810790442822
DOI https://dx.doi.org/10.2174/157488810790442822 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Palmitoylethanolamide Restores Myelinated-Fibre Function in Patients with Chemotherapy-Induced Painful Neuropathy
CNS & Neurological Disorders - Drug Targets An Overview of Acute Flaccid Myelitis
CNS & Neurological Disorders - Drug Targets State of the Art of Biochemical Markers in Metastatic Bone Disease and the Role of Bisphosphonates as Therapeutic Agents
Current Pharmaceutical Analysis Non-transfusion Dependent Thalassemias: A Developing Country Perspective
Current Pediatric Reviews The Role of MDCT in Craniocervical Junction Pathologies: Pictorial Review
Current Medical Imaging Regenerative Potential of Stem Cell-derived Extracellular Vesicles in Spinal Cord Injury (SCI)
Current Stem Cell Research & Therapy Multiple Protective Functions of Sigma1 Receptor
Current Protein & Peptide Science Therapeutic Strategy of Erythropoietin in Neurological Disorders
CNS & Neurological Disorders - Drug Targets New Development and Application of Ultrasound Targeted Microbubble Destruction in Gene Therapy and Drug Delivery
Current Gene Therapy Zoledronic Acid -a Multiplicity of Anti-Cancer Action
Current Medicinal Chemistry Elucidation of Pathophysiology and Treatment of Neuropathic Pain
Central Nervous System Agents in Medicinal Chemistry Imaging and Clinical Features of Neurocutaneous Melanosis in the Pediatric Population
Current Medical Imaging Fecal Incontinence in Children and Adolescents
Current Pediatric Reviews Preparation and Characterization of a Conduit for Peripheral Nerve Regeneration
Current Applied Polymer Science Anesthesia Issues in Central Nervous System Disorders
Current Aging Science Naturally Occurring and Related Synthetic Cannabinoids and their Potential Therapeutic Applications
Recent Patents on CNS Drug Discovery (Discontinued) Stability, Disposition, and Penetration of Catalytic Antioxidants Mn-Porphyrin and Mn-Salen and of Methylprednisolone in Spinal Cord Injury
Central Nervous System Agents in Medicinal Chemistry Pituitary Stem Cells Drop Their Mask
Current Stem Cell Research & Therapy Advances in the Use of Stem Cells and Tissue Engineering Applications in Bone Repair
Current Stem Cell Research & Therapy Neonatal Germ Cell Tumors
Current Pediatric Reviews